Our Mission:
to set the global standard in the management of provenance and integrity of biological assets while biosafety and biosecurity underpin all of our activities.
We pioneer innovations that enhance the integrity and traceability of engineered biological assets through our proprietary DNA signature technology.
Our diverse team of experts is dedicated to advancing the potential of synthetic biology and engineering biology worldwide by securing the supply chain of engineered biological assets.
Our Mission
At GitLife Biotech, our mission is to set the global standard in the management of provenance and integrity of biological assets while biosafety and biosecurity underpin all of our activities.
We are driven each day to ensure the potential of synthetic biology is realised worldwide.
Our Vision
Our vision is to enable the global community to safely and seamlessly develop, commercialise, deploy and trace engineered biological assets.
our story, so far...
GitLife Biotech’s journey has been marked by numerous exciting milestones that reflect our commitment to innovation, excellence, and collaboration.
From our incorporation to securing prestigious grants and forming valuable partnerships, our timeline highlights the rapid growth and significant achievements that have shaped our story.
Click around below to learn more about our journey so far and key milestones.
GitLife Biotech Incorporation
GitLife Biotech was officially incorporated, marking the beginning of our mission to set new standards in synthetic biology and biological asset management.
Spin Out from Newcastle University
GitLife spun out from Newcastle University, leveraging cutting-edge academic expertise to drive innovation in synthetic biology solutions and enhance transparency, essential for advancing engineering biology and managing intellectual property rights
First Fundraise Close
We successfully closed our first fundraising round, securing crucial resources to accelerate our research and development initiatives.
Investor Partnership Grant
We commenced our Investor Partnership Grant under the Future Economy Investor Partnerships SME Round 1 (Innovate UK), enhancing our capacity to develop cutting-edge technologies.
Tech Kickstarter 2.0 Competition Win & NCIMB Collaboration Grant
GitLife Biotech won the Tech Kickstarter 2.0 competition, showcasing our innovative solutions and solidifying our reputation as a leader in synthetic biology. Learn more.
Additionally, our collaboration grant with NCIMB started under the Engineering Biology Collaborative R&D Round 2 This partnership will see GitLife Biotech technology to securely barcode and organise biological data, linking it to our biosecurity platform Learn more.
Initial Team Expansion
We expanded our team by hiring a Molecular Microbiologist, Bioinformatician, and Policy & Regulatory Analyst, strengthening our team’s expertise and capabilities.
Participation in SynBioBeta 2024
Our team attended SynBioBeta 2024, a leading event for synthetic biology, where we showcased our latest innovations and networked with industry leaders. Learn more
Grand Scale Kickstart for ICURe
GitLife Biotech was selected for the Grand Scale Kickstart for ICURe, highlighting our potential to scale and significantly impact the synthetic biology sector.
Planned Team Expansion
By the end of 2024, we plan to further expand our team, bringing in more talent to drive our mission forward and achieve many new milestones in synthetic biology.
meet the gitLife team.
our technologies
Cell and Biological Assets Engineering with Version Control
CellRepo™ is our revolutionary platform that brings version control to engineering biology. This advanced system meticulously logs each modification. For example, microbial strains and plasmids can be tracked, ensuring complete traceability and management of biological assets.
With our proprietary GenoSignature® technology, every genetic change is recorded and easily retrievable, supporting robust and transparent research.
Technology: Ensuring Provenance and Integrity
GenoSignature® molecular technology is a unique feature of GitLife Biotech’s offerings. It provides a detailed history of genetic modifications, enhancing transparency and reliability in synthetic biology. This technology is critical for ensuring the integrity of biological materials and supporting robust genetic research.
making an impact
Our biosecurity products enable robust rights management, traceability and transparency, empowering confident distribution and manufacturing with clear ownership and accountability. Our innovative technologies and solutions are designed to address some of the world’s most pressing challenges, from industrial biotechnology, to healthcare, agriculture to environmental protection and bioenergy. By making a significant impact in these fields, we aim to establish a sustainable future.
contact us
Connect with us to explore our innovative solutions in cell engineering and genetic modification. Whether you’re interested in our cutting-edge CellRepo™ platform, or our GenoSignature® technology, our team is here to support your research and development projects through effective biological asset management solutions.
Careers: Our Current vacancies.
If there is no suitable role listed above, but you’d like to be considered for future vacancies, we’d love to hear from you!
